El-Harakeh Mohammad, Rodriguez-Tirado Felipe, Hardman Andrew J, Miehls Alexa, Camara Oumoulkhairy, Grounds Kelly M, Tocaj Glenis, Kercsmar Macie, Li Birong, Wang Xin, Becknell Brian, Jackson Ashley R
Kidney and Urinary Tract Center, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA.
Division of Nephrology and Hypertension, Nationwide Children's Hospital, Columbus, OH, USA.
Exp Mol Med. 2025 May 1. doi: 10.1038/s12276-025-01441-0.
Urinary tract obstruction (UTO) is a common cause of kidney injury that can result in chronic kidney disease and end-stage renal disease. Heterogeneity in the extent of obstructive renal damage in humans with UTO implies the existence of unknown mechanisms that protect against or accelerate kidney injury. Prior studies show that congenital and acquired UTO initiate a conserved, protective program of renal urothelium remodeling that culminates in expansion of uroplakin (UPK) cells to promote renal structural integrity. However, the cellular and molecular mechanisms that regulate UPK expression in the renal urothelium are unknown. Peroxisome proliferator-activated receptor γ (PPARγ) drives urothelial differentiation and UPK expression in other tissues but has not been investigated in the renal urothelium. Here we demonstrate that activation of PPARγ in UPK cells is critical for UTO-induced renal urothelium remodeling. Conditional deletion of Pparg perturbs UPK expression and accelerates parenchymal thinning during UTO, while conditional activation of PPARγ increases UPK expression and results in parenchymal preservation. This study underscores the significance of renal urothelium during UTO and shows that UTO-induced renal urothelial remodeling is achieved through activation of PPARγ. These findings form the foundation for future studies that will determine the therapeutic utility of PPARγ agonists during congenital and acquired UTO.
尿路梗阻(UTO)是导致肾损伤的常见原因,可引发慢性肾脏病和终末期肾病。UTO患者梗阻性肾损伤程度的异质性表明存在未知的保护或加速肾损伤的机制。先前的研究表明,先天性和后天性UTO会启动一个保守的、保护性的肾尿路上皮重塑程序,最终导致尿血小板溶素(UPK)细胞扩张,以促进肾脏结构完整性。然而,调节肾尿路上皮中UPK表达的细胞和分子机制尚不清楚。过氧化物酶体增殖物激活受体γ(PPARγ)可驱动其他组织中的尿路上皮分化和UPK表达,但尚未在肾尿路上皮中进行研究。在此,我们证明UPK细胞中PPARγ的激活对于UTO诱导的肾尿路上皮重塑至关重要。Pparg的条件性缺失会扰乱UPK表达,并在UTO期间加速实质变薄,而PPARγ的条件性激活会增加UPK表达并导致实质保留。本研究强调了肾尿路上皮在UTO期间的重要性,并表明UTO诱导的肾尿路上皮重塑是通过PPARγ的激活实现的。这些发现为未来研究奠定了基础,这些研究将确定PPARγ激动剂在先天性和后天性UTO中的治疗效用。